Nina Shah @ninashah33 Twitter profile

Last Seen Profiles

@c4lori

@ArsenalReveal

@caryclack

@CoachWesCope

@craigcalcaterra

@NationalQBClub

@IVECOUK

@Rachel_L_Bender

@DumbDaintyDaisy

@NedtzoArt

@ZensProducer

@JohnstoneYT

@PennyJayP

@RemyLeBruh

@alexandradarch

@dklairEd

@MayorofTexas

@Weezeytimes

@bagley_cole

@JusCallMeLani

@producedxapollo

@tsf_customsigns

@WhosKateStrange

@AlfieGWhattam

@jaylacuateco

@PreciousGNSD

@kulo_jawa01

@maurosaiete

@mplidofficial

@ruawnmei

@tanakenjapan

@CoraMaay

@CaseyStern

@WonderTheMovie

@Fibenheimer

@ObiWorldwide

Nina Shah

@ninashah33

5 years

After a whirlwind myeloma round table, I think I have to face the music and proclaim myself as Myeloma Millennial aka #myelennial See inclusion criteria below (must meet 3). @IreneGhobrial @Rfonsi1 @akeithstewart @SLentzsch @Leif_Bergsagel @EagleMyeloma Anything to add?? #mmsm

19

35

173

Nina Shah

@ninashah33

3 years

Sometimes it’s ok to meet outside of an oncology conference… @rachnatshroff

4

3

172

Nina Shah

@ninashah33

2 years

So excited for another option for our patients ! CAR-T PAR-TY!! J&J, Legend cell therapy approved by FDA for multiple myeloma | BioPharma Dive ⁦ @SandyWong02111 ⁩ ⁦ @TomBmt133 #mmsm

J&J, Legend cell therapy approved by FDA for multiple myeloma

The CAR-T treatment is the second to be approved in the U.S. for the blood cancer, following Bristol Myers Squibb and 2Seventy bio's Abecma.

www.biopharmadive.com

4

26

162

Nina Shah

@ninashah33

4 years

I’m an Indian-American woman who grew up in Delaware ... so you know what’s up !!!!

5

154

Nina Shah

@ninashah33

3 years

Y'all: too much #myelomaresearch goodness to boil it down to Top 10. So here is my #ASH20 Top 10 for bispecifics/ADC's/CAR T. In short - the bispecifics are this year's homecoming queen... More to come... #mmsm

7

27

150

Nina Shah

@ninashah33

2 years

Congratulations to @mvmateos (my #styeloma queen) for winning the Bart Barlogie award and @NoopurRajeMD for winning the Ken Anderson award. Inspiring and amazing #woMMen #mmsm #IMS2022

3

19

146

Nina Shah

@ninashah33

3 years

Huge news!! Bristol Myers Squibb - U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma...

Abecma is a first-in-class BCMA-directed personalized immune cell therapy delivered as a one-time infusion for triple-class exposed patients with multiple myeloma1 In the pivotal KarMMa trial, the...

news.bms.com

0

26

147

Nina Shah

@ninashah33

2 years

Watch out #myeloma … we are back! #mmsm #woMMen @IreneGhobrial

3

5

145

Nina Shah

@ninashah33

2 years

We are BACK-SCO ! ⁦ @rachnatshroff ⁩

5

2

120

Nina Shah

@ninashah33

2 years

You know I must love being a myeloma doc to make it here at 645 am EST = 345 PST. 😆 #mmsm @theMMRF @elimanasanch @AkrishnanUsa

7

3

119

Nina Shah

@ninashah33

2 years

Could not be happier for my big bro and #frientor @jmikhaelmd and @EmilyVanLaar #DMC @szusmani @Ccostello7 @rabonour1 @ZainabShd @Rfonsi1 #jemforever

20

8

119

Nina Shah

@ninashah33

5 years

The woMMen of myeloma: watch out cancer, we are coming for you !!! @IreneGhobrial @SurbhiSidanaMD @SandyWong02111 #mmsm #IMW2019

7

13

106

Nina Shah

@ninashah33

4 years

Social distancing cannot keep our @UCSF #myeloma team apart! @SandyWong02111 @TomBmt133 @myelomawolf #mmsm

3

4

108

Nina Shah

@ninashah33

3 years

In true heme fashion my awesome UCSF faMYELy threw me a “Day (-1)” surprise birthday party! Sparkling water & birthday pies 🥳 This is why it’s a blessing to love the people you work with! Thank you @SandyWong02111 @TomBmt133 @myelomawolf @AlfredChung11 @shagunaroramd #45andalive

13

1

106

Nina Shah

@ninashah33

2 years

Mentor + FRIENtors. My ❤️is full after reconnecting with my OG mentor: the legendary @EjShpall - the only reason I am anywhere in my career today. @MDAndersonNews @DrKrinaPatel @sairah__ahmed #tct2022

5

8

106

Nina Shah

@ninashah33

2 years

Cilta can SELL! CARTITUDE-1 updated cilta-cel data: 98% ORR, 95% VGPR or better. PFS of 60.5% at 2 y !!! It’s gonna beat 2 y!! No new major safety issues. MRD neg people did even better (of course!). Congrats to @TomBmt133 et al #mmsm #ASH21

3

32

104

Nina Shah

@ninashah33

1 year

Well, it wouldn’t be #ASH22 without the plane from SFO chock full of pharma/biotech/ UCSF 😆

2

3

103

Nina Shah

@ninashah33

3 years

Is it weird to have vaccine FOMO??? #VaccinesWork

11

0

99

Nina Shah

@ninashah33

2 years

Congratulations to my #bestie @rachnatshroff on her election to @ASCO Nominating Committee!! “She’s ma best freyyynd!”

ASCO

@ASCO

2 years

🎉Congrats to our newly elected BOD and Nominating Cmte members who assume their new roles in June 2022🎉

17

35

169

7

97

Nina Shah

@ninashah33

9 months

Ready to celebrate our @DrKrinaPatel ! #bridetribe

3

1

96

Nina Shah

@ninashah33

4 years

GSI: so fly!! BCMA CAR T +gamma decretase inhibitor with ORR 100%, even in pts with prior anti BCMA therapy. #mmsm @andrewcowanmd #ASH19

8

40

92

Nina Shah

@ninashah33

5 years

Ok hands down best poster of #IMW2019 Being married associated with better MM survival. Question from @myelomawolf aka Jeff: “well what if you’ve been married 3x??” 😆

5

15

93

Nina Shah

@ninashah33

4 years

Some pics from our Women in Myeloma event aka #woMMen . Thank you to the women leaders and the #HeForShe men who came out to offer advice and support @TomBmt133 @jmikhaelmd @szusmani @IreneGhobrial . #whorundaworld #mmsm

4

16

86

Nina Shah

@ninashah33

4 years

I know I'm a #latebreaker but here are my top 10 abstracts for #ASH19 (no particular order). I tried to focus on things that might affect my practice in the next 2 years. @SandyWong02111 @UCSFCancer @TomBmt133 @myelomawolf

2

31

88

Nina Shah

@ninashah33

5 years

Best #ASH2018 life hack ever ! Meeting material pick up at baggage claim ?! Love it !!

3

8

91

Nina Shah

@ninashah33

4 years

My Top #ASCO20 #myeloma abstracts. Missing the meeting, but not the Tweeting!! #mmsm @szusmani @myelomaMD @Phari @BerdejaJesus

0

23

87

Nina Shah

@ninashah33

2 years

#myelebrities sure know how to make a girl feel good on her birthday! Thank you @DMadduri for organizing! @IreneGhobrial @DrKrinaPatel @AuclairDan @szusmani @AjayNookaMD @myelomatips @SandyWong02111

4

2

92

Nina Shah

@ninashah33

3 years

Getting started soon! A session you won’t wanna miss! Only bad thing about moderating is it makes it hard to tweet!!! 😆 #mmsm #ASH20

2

9

86

Nina Shah

@ninashah33

2 years

#Tandem22 session on #SoMe was a success! Thank you to @AkshaySharmaMD for organizing and applause to my co-panelists @sghmd @DrMiguelPerales @PergamIC & @drkomanduri - each of whom gave me something to think about

0

9

88

Nina Shah

@ninashah33

3 years

Car-cy-dex: shockingly this is NOT a T cell therapy!! 😆KCD with weekly K in RRMM >KD -Impressive data esp in len refractory pts. Kudos to the team for doing something pharma probably doesnt want to do but I personally use this combo a lot. Congrats to @mvmateos #mmsm #ASH20

3

20

81

Nina Shah

@ninashah33

3 years

On in patient service this year —> I’m doing this half-ASH 😆 #mmsm #ASH20

4

3

80

Nina Shah

@ninashah33

5 years

In a hut on top of an Icelandic mountain next to a glacier. Thank you @GSK for letting us have this experience with #myeloma patients and caregivers @theMMRF @MMRFTeam4Cures @cure_magazine #mmsm @HemeResearcher

4

8

79

Nina Shah

@ninashah33

3 years

Since we can’t solve #burnout in a day can we at least have consensus for universal login & password for all #PubMed journals ?!? Can’t tell you the number of times I have to hit “reset password” just to review a paper. Add all the time together & I could‘ve seen at least 2 pts!

7

2

79

Nina Shah

@ninashah33

2 years

In honor of #WomensEqualityDay yesterday: I was thrilled to be in the presence of these fabulous woMMen @DrKrinaPatel @SandyWong02111 @IreneGhobrial @Ccostello7 @AkrishnanUsa @TaraGregoryMD @mvmateos @NoopurRajeMD @SurbhiSidanaMD @UrviShahMD

1

11

81

Nina Shah

@ninashah33

3 years

Finally! People can use “melanoma” and “myeloma” in the same sentence! BRAF & MEK dual inhibition in BRAF mutated RR #myeloma . 83% ORR! So exciting to see novel application of already established ALL ORAL and no-Dex targeting therapy #mmsm #ASH20

3

15

77

Nina Shah

@ninashah33

5 months

My swan song meeting as plasma cell sci committee chair! 😔 Thank you to @ASH_hematology for an inspiring 5 years! Take it away Paola! @FrancescoMaura4 @DavidJChungMD @PedalheadPHX @_DrCP #mmsm #ASH23

1

5

80

Nina Shah

@ninashah33

2 years

My fave moments from the #IMS2022 faculty dinner last night. Yes I’m now just a +1 … but you know I can still rock the selfies! #mmsm @DrKrinaPatel @Rfonsi1 @SandyWong02111 @AkrishnanUsa @TomBmt133 @apwiita @IreneGhobrial @IvanBorrello @SurbhiSidanaMD @BerdejaJesus @UrviShahMD

5

7

77

Nina Shah

@ninashah33

4 years

So grateful for my #myeloma friends for organizing our virtual half marathon to promote the #Move4Myeloma platform. Great way to combine physical and emotional well-being ❤️ #mmsm #coastocoast @AuclairDan @IreneGhobrial @szusmani @MMRFTeam4Cures

2

5

74

Nina Shah

@ninashah33

3 years

Excellent poster discussion by @SandyWong02111 on #myeloma #ASCO21 abstracts for RRMM. In short , triplets>>doublets, dara after isa no good, ixa-dex=Pom-dex. @UCSFCancer #mmsm

3

16

78

Nina Shah

@ninashah33

4 years

Happy “Cinco de Myeloma” from your favorite #myelebrities !! You know this COVID thing can’t bring a good party down! #mmsm @smalveira23 @DMadduri @TomBmt133 @myelomatips @agarwalonc @szusmani (please note @kaufman_MMdoc ‘s Viking hat sombrero...)

2

6

73

Nina Shah

@ninashah33

2 years

Digital Life Coaching during Stem Cell Transplantation: A Pilot Feasibility Study - PubMed Super proud of my mentee ⁦ @RahulBanerjeeMD ⁩ for bringing this project to life. Supportive care is about more than just medications! #mmsm ⁦ @UCSFCancer ⁩

Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study - PubMed

ClinicalTrials.gov NCT04432818; https://clinicaltrials.gov/ct2/show/NCT04432818.

pubmed.ncbi.nlm.nih.gov

5

17

78

Nina Shah

@ninashah33

2 years

Words cannot capture how proud I am of my friend,fellow woMMen,& #myelomasister ⁦ @IreneGhobrial ⁩ for winning this prestigious award; she’s personifies vision& diligence: ASH Announces 2022 Honorific Award Recipients -

3

7

76

Nina Shah

@ninashah33

2 years

Happy Diwali to all, esp my #DMC family @DrKrinaPatel @szusmani @SagarLonialMD @DMadduri @AkrishnanUsa @AjayNookaMD @adsouza_md @myelomaMD @Transplant_Doc @RahulBanerjeeMD & so many others ! Wishing everyone a year of light and happiness 🪔

8

6

75

Nina Shah

@ninashah33

5 years

Looking forward to presenting the first clinical results from @bluebirdbio bb21217 anti BCMA CAR T cells for relapsed #myeloma : 430 pm. Room 6B Session 801 @SandyWong02111 @TomBmt133 @UCSF #mmsm #ASH18

6

12

72

Nina Shah

@ninashah33

2 years

#ASCO22 starter selfies with @rachnatshroff and @DrKrinaPatel #sisters

3

2

73

Nina Shah

@ninashah33

3 years

Our #myeloma @ASCO ed chapter is out! #mmsm @RahulBanerjeeMD @DoctorAKrishnan When and How to Treat Relapsed Multiple Myeloma

When and How to Treat Relapsed Multiple Myeloma

The treatment landscape for relapsed multiple myeloma has expanded considerably in recent years, as numerous agents with new mechanisms of action have been introduced, increasing responses even in...

ascopubs.org

4

22

74

Nina Shah

@ninashah33

2 years

BCMAgain!! @UCSFCancer analysis of salvage therapy post CAR-T shows best therapies are other BCMA therapies. Congrats to our 2nd y Med student (!!!) @Kevin_Reyes650 and mentors @AlfredChung11 & @RahulBanerjeeMD #mmsm #IMS2022

0

16

74

Nina Shah

@ninashah33

5 years

#Insta -DARA! Subcutaneous Daratumumab = IV Dara. Of all the abstracts so far this am I think this might be the one that improves #QOL the most (for pts AND docs / infusion centers) @mvmateos #ASC019 #mmsm

2

24

68

Nina Shah

@ninashah33

2 years

#myelebrity + #myelennial poster walk #mmsm #ASCO22 @szusmani @DrKrinaPatel @andrew02114

1

3

75

Nina Shah

@ninashah33

4 years

MRD is the place to be! Check out our latest paper on value of measuring/following MRD by NGS for #myeloma @TomBmt133 @SandyWong02111 @myelomawolf @UCSFCancer

Clinical value of measurable residual disease testing for assessing depth, duration, and direction...

Key Points. We explore the important role of the clinical value of MRD use in the real-world practice in MM.We address new topics in the field of MRDs, inc

ashpublications.org

2

13

68

Nina Shah

@ninashah33

1 year

My dirty December secret: I finally completed unpacking my #ASH22 suitcase this evening…

3

0

73

Nina Shah

@ninashah33

2 years

Vienna rooftop dining with some of my fave #myelebrities @IreneGhobrial @AuclairDan #EHA22 #mmsm

2

4

74

Nina Shah

@ninashah33

5 months

Thank you to @ASCOPost for this profile piece. Being an oncologist is one of the greatest careers of all, esp for women. Also love that they featured my kids and Dennis, my fave @onepeloton instructor ! #HERmatology

The ASCO Post

@ASCOPost

5 months

Supportive Parents and Early Love of Science Lead to a Career in Hematology Oncology for Nina Shah, MD @ninashah33

3

7

39

4

7

75

Nina Shah

@ninashah33

1 year

As a recent investigator and practicing hematologist I’m thrilled that @AstraZeneca is taking concrete steps to decrease gender inequality in hematology clinical research

Susan Galbraith

@susanmgalbraith

1 year

Ensuring gender balance is good for innovation, business and society. At #ASH22 we are kicking off a bold initiative that aims to help women in haematology break barriers to gender inequality #HERmatology .

1

9

46

1

11

75

Nina Shah

@ninashah33

3 years

First in person ad board in 2 years! Being in the same room really DOES make a difference for exchange of ideas. (I promise we were COVID safe!!) #mmsm @PlasmaCellPete @elimanasanch @rajshekharucms @andrew02114 @EhsanMalekMD

1

2

72

Nina Shah

@ninashah33

4 years

Happy holidays from the USCF myeloma team !! @UCSFCancer @TomBmt133 @SandyWong02111 @myelomawolf #mmsm

2

1

69

Nina Shah

@ninashah33

2 years

My #LEAD2022 co-chairs! Such a privilege to see our dream of a women’s leadership meeting come to reality. Thank you @BioAscend and all the faculty and attendees @DrJulieVose @JulieBrahmer

3

9

72

Nina Shah

@ninashah33

3 years

Here are my "other" Top 10 #ASH20 (non-BCMA/ T cell) #myeloma abstracts. Mainly supporting my love of transplant, Peloton and novel combo therapy #mmsm

3

15

69

Nina Shah

@ninashah33

3 years

CARTITUDE magnitude! Cilta-cel ORR 97% and 12 mo PFS 77% in very heavily pre treated #myeloma Congrats to @DMadduri and @TomBmt133 for a spectacular study! #mmsm #ASH20

3

18

70

Nina Shah

@ninashah33

2 years

Cinco de myeloma was a success! 🌮 Love the @UCSFCancer team @TomBmt133 @SandyWong02111 @myelomawolf @KristenHege

4

71

Nina Shah

@ninashah33

8 months

DLC from the #DMC ! Randomized Ph II study of digital life coaching during ASCT recovery. Of course @RahulBanerjeeMD and I had to hype the poster up! We started thinking about this study in 2018 😮 So happy to see it completed and in print #mmsm #IMS23 @UCSFCancer

3

2

72

Nina Shah

@ninashah33

2 years

Thrilled to be featured in this interview with my new team at @AstraZeneca for #BloodCancerAwarenessMonth ! Even a few weeks at my new job has given me additional perspective on the unmet needs in #multiplemyeloma and #bloodcancers as a whole. #mmsm

Anas Younes, M.D.

@DrAnasYounes

2 years

Check out my latest article: It’s In My Blood – Nina Shah, Global Head of Multiple Myeloma Clinical Development and Strategy, Oncology at AstraZeneca via @LinkedIn

0

3

34

4

7

72

Nina Shah

@ninashah33

5 years

And I’m off! SFO—> Reykjavik Ready to trek with the @MMRF ! You guys (and my awesome patients) have helped me to raise $11,000 THANK YOU ALL - still time to donate!! #mmsm

4

6

68

Nina Shah

@ninashah33

1 year

Great to reunite with my @CIBMTR colleagues for my final year 😢 as co-chair on the plasma cell disorders committee #mmsm #Tandem23 @mpasca @Transplant_Doc @LandauHeather

0

7

70

Nina Shah

@ninashah33

2 years

“It’s complicated…” Fantastic lecture by Paola Neri on immune status in plasma cell disorders. You can’t deny the back and forth permissive/ protection between immune system and MM as well as effects on therapy response. #mmsm #IMS2022

0

15

68

Nina Shah

@ninashah33

2 years

Was only there for a day but managed to get some quality #ASH21 selfies. I promise we only took the masks off for the pics !! @DrKrinaPatel @DMadduri @jmikhaelmd @SLentzsch @benofzongo

2

6

69

Nina Shah

@ninashah33

4 years

Desi Female Myeloma Consortium #DFMC #mmsm Rockin’ the BCMA... @DMadduri #TCTM20

0

1

65

Nina Shah

@ninashah33

11 months

Congratulations to my #unicornboss 🦄 @TomBmt133 on the prestigious Brian G Durie award. So sad not there in person to celebrate you! You’ve changed the lives of so many MM pts… and you def changed my life for the better !! ❤️ @UCSFCancer 4-eva! @myelomawolf @SandyWong02111

4

7

67

Nina Shah

@ninashah33

4 years

“STOMP out MM!” Selinexor-dara-dex with ORR of 73% in dara-naïve pts, median PFS 12.5 mo. RP2D = selinexor 100 mg. Gr 1-2 nausea=62%. Enjoying seeing the data mature, we need to learn how to use this drug. congrats to @Cristin53875581 #mmsm #ASCO20

1

22

66

Nina Shah

@ninashah33

2 years

So excited about this year’s #LEAD2022 meeting in person (🎉🎉🎉) in Santa Monica. Women make up half of oncology- this should be reflected in pubs, podiums and positions of leadership @DrJulieVose @JulieBrahmer

1

13

64

Nina Shah

@ninashah33

4 years

MASS-ive! Mass-spec based MRD analysis in HR SMM: more sensitive than SPEP/IFE and possibly NGF. Most importantly no BM required for this !! Would love to shift over to this to improve patient experience #mmsm #ASH19 @mvmateos

2

24

65

Nina Shah

@ninashah33

6 years

“Week” in the knees!! - Mateos et al: weekly carfilzomib with improved PFS against twice weekly, same safety #ASCO2018 #myeloma

4

39

62

Nina Shah

@ninashah33

3 years

So awesome to share the stage with these #myelebrities at the #GDU2021 - debating the latest and greatest in #myeloma #mmsm @Ccostello7 @Ashley_Rosko1 @VincentRK @jmikhaelmd @DrSarahHolstein

3

10

62

Nina Shah

@ninashah33

4 years

ready to go! #ASH Meeting on Hematologic Malignancies #myeloma case reviews! @IreneGhobrial @MorieGertz @vsanchorawala @VincentRK #mmsm

3

2

59

Nina Shah

@ninashah33

4 years

A CAR with a ‘tude ! CARTITUDE-1 BCMA CAR T results with impressive 97% >VGPR and 9 mo PFS 86% (n=29). Safety similar to other products. Very much looking forward to longer FU from phase 2 study. #mmsm #ASCO20 @BerdejaJesus @DMadduri

1

37

62

Nina Shah

@ninashah33

9 months

Congratulations to the happy couple! @DrKrinaPatel ! Love celebrating with @doctorpemm , @EJShpallMD and @DoctorGRao

4

2

64

Nina Shah

@ninashah33

5 years

Don’t ax venetoclax!! T(11:14) patients can benefit and we can probably manage the infections. @myelomaMD #mmsm #IMW2019

2

21

62

Nina Shah

@ninashah33

5 years

“Oh MAIA!” Dara-Rd >>Rd in ASCT intelligible NDMM pts. PFS not reached vs 31.9 mo. HR 0.56, deeper responses. Maybe a little more neutropenia in DRd but o/w well tolerated. Important to note: 80% pts age >70 #mmsm #ASH18 @tanyawildes right?

7

26

61

Nina Shah

@ninashah33

2 years

“CAR-T rockin in the house tonight…” The brilliant @DrKrinaPatel discussing how we will integrate CAR T therapy amidst the limitations, promise and myriad of therapies in #myeloma #mmsm #IMS2022

0

18

59

Nina Shah

@ninashah33

3 years

Love starting my Saturday AM with the #myelebrities @jmikhaelmd @Ashley_Rosko1 @Ccostello7 @Rfonsi1 Great Debates and Updates Hematologic Malignancies! #mmsm

5

7

59

Nina Shah

@ninashah33

5 years

LBA session. Looking forward to this session. But we need more women up there (even 1!) #ASH18

6

11

57

Nina Shah

@ninashah33

4 years

In the words of CeCe Peniston...”Finally!!!” #mmsm #CARTcell

The Myeloma Beacon

@myelomabeacon

4 years

The U.S. FDA has accepted the new drug application for the investigational #myeloma therapy ide-cel (idecabtagene vicleucel, bb2121) and granted the application priority review. More details in this press release from BMS & bluebird bio:

1

14

19

2

11

57

Nina Shah

@ninashah33

4 years

We are pleased to announce registration for the 2nd annual LEAD conference: Leadership, Empowerment and Development. A truly transformative experience for women in oncology. Oct 2-3; Santa Monica CA #LEAD2020 @BioAscend @DrJulieVose @brahmer

4

20

59

Nina Shah

@ninashah33

2 years

That’s my bestie !!! Congratulations to @rachnatshroff A mentor, leader and warrior against cancer!

University of Arizona COM - Division of Heme/Onc

@UAZHemeOnc

2 years

Congratulations to our @UAZHemeOnc Interim Division Chief Dr. @rachnatshroff for winning the 2022 Faculty Mentoring Award at the @UAZMedTucson Faculty Excellence awards banquet! @UAZCancer

18

126

2

4

58

Nina Shah

@ninashah33

4 years

“Mark” my words! T(11:14) and high Bcl2 are predictive biomarkers for response to ven-bortez-dex. PFS not reached yet! Time to move on from the Bellini drama and study ven specifically in this subgroup of pts. #mmsm #ASH19

0

28

55

Nina Shah

@ninashah33

5 years

A bunch have you have asked me what #myelennial means: here you go! #jointhemovement

Nina Shah

@ninashah33

5 years

After a whirlwind myeloma round table, I think I have to face the music and proclaim myself as Myeloma Millennial aka #myelennial See inclusion criteria below (must meet 3). @IreneGhobrial @Rfonsi1 @akeithstewart @SLentzsch @Leif_Bergsagel @EagleMyeloma Anything to add?? #mmsm

19

35

173

1

11

52

Nina Shah

@ninashah33

1 year

Love being able to reconnect with my @MDAndersonNews co-fellows and faculty. We are bonded for life ❤️ #DAVAWhistler @OMIonc @doctorpemm @TapKadia @Lymphoma_Doc @sairah__ahmed @NitinJainMD

5

4

60

Nina Shah

@ninashah33

5 years

Introducing the first annual LEAD conference: an opportunity for leadersihp, education and development for WOMEN in #oncology . So excited about this agenda; hope you can join @DrJulieVose , Dr. Julie Brahmer and me for this exciting event. Register at

0

19

57

Nina Shah

@ninashah33

3 years

Amazing discussion by my #CRTI mentee and CA superstar @SurbhiSidanaMD on the novel immunotherapies and how we may choose between them, what to do after relapse (biggest q in my mind!) #DMC #mmsm #ASCO21

5

15

56

Nina Shah

@ninashah33

4 years

B-cell maturation antigen (BCMA) is an important potential target being investigated in multiple myeloma.

2

9

50

Nina Shah

@ninashah33

4 years

Such an inspiring story. Did you know this guy was a radiation oncologist before he was the ruler of all things transplant-related ?? Congrats @BldCancerDoc PS I didn’t know you got a second dog 🐕!!

The ASCO Post

@ASCOPost

4 years

#LivingAFullLife : Navneet S. Majhail, MD, MS, Was Inspired by His Father’s Career as a Military Doctor and His Mother’s Battle With Cancer

0

28

92

1

7

59

Nina Shah

@ninashah33

2 years

Let’s get this party started! 🎉Ready for #myeloma oral abstract session with my co-chair @ravivij #mmsm #ASCO22 Join us in room S406

3

5

58

Nina Shah

@ninashah33

2 years

Ready for our our rockin symposium: “The road to personalized treatment in multiple #myeloma ” -representing 4 countries and a span of 9 time zones @HangQuach1 #EHA22 #mmsm

1

7

58

Nina Shah

@ninashah33

3 years

Regenerate! REGN5458 BCMA bispecific. 63% ORR in highest DL. Are the bispecifics to CARs what the Backstreet Boys were to NKOTB ?!Congrats to @DMadduri #mmsm #ASH20 #DMC

2

12

57

Nina Shah

@ninashah33

3 years

There are very few people I admire as much as @szusmani - truly thrilled to see his accomplishments recognized. So grateful to have him as my colleague and brother. He has pushed and inspired me to be better in so many ways. Congratulations on your award!! #mmsm #DMC

Daniel Auclair

@AuclairDan

3 years

⁦ @szusmani ⁩ , Brilliant clinician, compassionate doctor, Superman, super dad and husband, and now Bart Barlogie Awardee. Congrats and well done my friend #IMW21 #IIMW2021 #mmsm

8

7

95

1

4

58

Nina Shah

@ninashah33

4 years

Something to chew on! Teclistamab BCMA-CD3 BiTE with impressive ORR 67% at top dose, heavily pre-tx'd population. I am most impressed with DOR, even at lower doses! Congrats to @szusmani and also @TomBmt133 for an excellent overview of this exciting technology #mmsm #ASCO20

2

16

56

Nina Shah

@ninashah33

2 years

My fave #EHA selfies part 1 @TomBmt133 @jmikhaelmd @DMadduri @mvmateos @myelomatips

0

58

Nina Shah

@ninashah33

2 years

Happy birthday to my fave Myeloma T-Rex @Rfonsi1 !!! You are loved by all your colleagues, mentees and patients #mmsm

4

2

54

Nina Shah

@ninashah33

5 years

Don’t bail on the frail! Weekly carfilz benefits frail MM pts just as much as the fit. Important analysis presented by @mvmateos - we have to optimize treatment for ALL patients ! #mmsm #IMW2019

1

14

54

Nina Shah

@ninashah33

4 years

Kicking off #ASH19 with some of my faves at the @MMRF MMRC meeting. Ready for another productive year to try to cure myeloma #mmsm @BerdejaJesus @AuclairDan

0

2

54